Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)
China
· Delayed Price · Currency is CNY 7.30
-0.05 (-0.68%)
Mar 11, 2026, 2:35 PM CST
SHE:002693 Revenue
Hainan Shuangcheng Pharmaceuticals had revenue of 84.78M CNY in the quarter ending September 30, 2025, with 164.39% growth. This brings the company's revenue in the last twelve months to 216.15M, up 19.66% year-over-year. In the year 2024, Hainan Shuangcheng Pharmaceuticals had annual revenue of 174.21M, down -26.16%.
Revenue (ttm)
216.15M
Revenue Growth
+19.66%
P/S Ratio
14.10
Revenue / Employee
357.27K
Employees
605
Market Cap
3.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 174.21M | -61.72M | -26.16% |
| Dec 31, 2023 | 235.93M | -38.82M | -14.13% |
| Jan 1, 2023 | 274.75M | -45.54M | -14.22% |
| Jan 1, 2022 | 320.29M | 50.85M | 18.87% |
| Dec 31, 2020 | 269.44M | -77.21M | -22.27% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 914.65M |
| Ginwa Enterprise (Group) | 550.44M |
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Guhan Pharmaceutical Group | 351.79M |
| Guizhou Yibai Pharmaceutical | 1.91B |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Enwei Pharmaceutical | 888.64M |
| Lionco Pharmaceutical Group | 430.61M |